Avenue Therapeutics, Inc. (ATXI) stock
ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.43+0.00 (0.00%)
Close on Oct 16, 2026Market cap $1.42MP/E –Yield –
Avenue Therapeutics cash
Cash and short-term investments held at the end of each period.
Avenue Therapeutics's cash was $1.94M at Jun 30, 2026. For fiscal 2025 it was $2.86M, up 10.1% from the year before. Over ten years it grew 70.2% a year on average. The highest annual figure on record is $21.78M in fiscal 2017.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.86M | +10.1% |
| FY2024 | Dec 31, 2024 | $2.59M | +45.5% |
| FY2023 | Dec 31, 2023 | $1.78M | -73.4% |
| FY2022 | Dec 31, 2022 | $6.71M | +78.3% |
| FY2021 | Dec 31, 2021 | $3.76M | +20.1% |
| FY2020 | Dec 31, 2020 | $3.13M | -64.2% |
| FY2019 | Dec 31, 2019 | $8.75M | +227.4% |
| FY2018 | Dec 31, 2018 | $2.67M | -87.7% |
| FY2017 | Dec 31, 2017 | $21.78M | +10956.9% |
| FY2016 | Dec 31, 2016 | $197.00K | +1307.1% |
| FY2015 | Dec 31, 2015 | $14.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.94M | -41.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.42M | -31.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.86M | +10.1% |
| Q3 FY2025 | Sep 30, 2025 | $3.71M | +42.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.33M | -32.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.50M | +9.6% |
| Q4 FY2024 | Dec 31, 2024 | $2.59M | +45.5% |
| Q3 FY2024 | Sep 30, 2024 | $2.60M | +1513.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.92M | +213.1% |
| Q1 FY2024 | Mar 31, 2024 | $3.19M | -61.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.78M | -73.4% |
| Q3 FY2023 | Sep 30, 2023 | $161.00K | -25.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.57M | +76.5% |
| Q1 FY2023 | Mar 31, 2023 | $8.24M | +349.3% |
| Q4 FY2022 | Dec 31, 2022 | $6.71M | +78.3% |
| Q3 FY2022 | Sep 30, 2022 | $217.00K | -62.9% |
| Q2 FY2022 | Jun 30, 2022 | $890.00K | -20.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.83M | +0.4% |
| Q4 FY2021 | Dec 31, 2021 | $3.76M | +20.1% |
| Q3 FY2021 | Sep 30, 2021 | $585.00K | -86.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.12M | -78.7% |
| Q1 FY2021 | Mar 31, 2021 | $1.83M | -72.2% |
| Q4 FY2020 | Dec 31, 2020 | $3.13M | -64.2% |
| Q3 FY2020 | Sep 30, 2020 | $4.33M | -68.5% |
| Q2 FY2020 | Jun 30, 2020 | $5.26M | -66.0% |
| Q1 FY2020 | Mar 31, 2020 | $6.57M | -77.7% |
| Q4 FY2019 | Dec 31, 2019 | $8.75M | +227.4% |
| Q3 FY2019 | Sep 30, 2019 | $13.74M | +186.0% |
| Q2 FY2019 | Jun 30, 2019 | $15.46M | +72.9% |
| Q1 FY2019 | Mar 31, 2019 | $29.45M | +96.8% |
| Q4 FY2018 | Dec 31, 2018 | $2.67M | -87.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.80M | -81.6% |
| Q2 FY2018 | Jun 30, 2018 | $8.94M | -74.2% |
| Q1 FY2018 | Mar 31, 2018 | $14.96M | +7495.4% |
| Q4 FY2017 | Dec 31, 2017 | $21.78M | +72506.7% |
| Q3 FY2017 | Sep 30, 2017 | $26.05M | +81306.3% |
| Q2 FY2017 | Jun 30, 2017 | $34.68M | – |
| Q4 FY2016 | Dec 31, 2016 | $197.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $30.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $32.00K | – |
See a number that looks wrong?